In our previous studies, the protection and anti‐inflammation potential of SPRC is dependent on its main synthetase CSE in heart injury and rheumatoid arthritis, and after inhibition of CSE, the positive potential of SPRC is abolished [25, 28, 56, 57]. This evidence concerns the gene SPRR3 and rheumatoid arthritis.